Literature DB >> 11268066

Labeling of Biomolecules for Medicinal Applications-Bioorganometallic Chemistry at Its Best The author thanks A. P. Schubiger and D. Grotjahn for reprints, and K. Severin for insightful discussions. The data in Figure 1 are used with the help and kind permission of M. Salmain and G. Jaouen. I am also grateful to Drs. H. & H. Weiss for their hospitality when writing this article.

Nils Metzler-Nolte1.   

Abstract

Entities:  

Year:  2001        PMID： 11268066     DOI： 10.1002/1521-3773(20010316)40:6<1040::aid-anie10400>3.0.co;2-p

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  4 in total

1.  Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.

Authors:  Sebastian Blanck; Thomas Cruchter; Adina Vultur; Radostan Riedel; Klaus Harms; Meenhard Herlyn; Eric Meggers
Journal:  Organometallics       Date:  2011-07-18       Impact factor: 3.876

2.  Synthesis and biological evaluation of tricarbonyl Re(I) and Tc(I) complexes anchored by poly(azolyl)borates: application on the design of radiopharmaceuticals for the targeting of 5-HT1A receptors.

Authors:  Raquel Garcia; Lurdes Gano; Leonor Maria; António Paulo; Isabel Santos; Hartmut Spies
Journal:  J Biol Inorg Chem       Date:  2006-07-06       Impact factor: 3.358

Review 3.  Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple strategies.

Authors:  Mehvash Zaki; Suboot Hairat; Elham S Aazam
Journal:  RSC Adv       Date:  2019-01-24       Impact factor: 4.036

4.  Synthesis and cyclometalation of a pyrido[3,2-e]-2,10b-diaza-cyclopenta[c]fluorene-1,3-dione scaffold.

Authors:  Seann P Mulcahy; Patrick J Carroll; Eric Meggers
Journal:  Tetrahedron Lett       Date:  2006-12-11       Impact factor: 2.415
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.